[³í¹®] 1. Yoo BS, Lee SH, Kim JY, Lee BK, Hwang SO, Choe KH, Yoon J. A case of transradial carotid stenting in a patient with total occlusion of distal abdominal aorta. Catheter Cardiovasc Interv 2002;56:243-5.
2. Yoo BS, Lee SH, Lee BK, Kim SN, Lee MO, Hwang SO, Choe KH, Yoon J. Procedural outcomes of repeated transradial coronary procedure. Catheter Cardiovasc Interv 2003;58:301-4.
3. Lee BK, Choi KJ, Kim J, Rhee KS, Nam GB, Kim YH. Right phrenic nerve injury following electrical disconnection of the right superior pulmonary vein. Pacing Clin Electrophysiol 2004;27:1444-6.
4. Park SJ, Kim YH, Lee BK, Lee SW, Lee CW, Hong MK, Kim JJ, Mintz GS, Park SW. Sirolimus eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation. J Am Coll Cardiol 2005;45:351-6.
5. Hong MK, Lee CW, Kim YH, Lee BK, Kim MK, Yang TH, Song JM, Han KH, Kang DH, Song JK, Kim JJ, Park SW, Park SJ. Two year follow up intravascular ultrasound analysis after bare metal stent implantation in 120 lesions. Catheter Cardiovasc Interv 2005;65:247-53.
6. Hong MK, Mintz GS, Lee CW, Lee BK, Yang TH, Kim YH, Song JM, Han KH, Kang DH, Cheong SS, Song JK, Kim JJ, Park SW, Park SJ. The site of plaque rupture in native coronary arteries: a three vessel intravascular ultrasound analysis. J Am Coll Cardiol 2005;46:261-5.
7. Seung KB, Kim YH, Park DW, Lee BK, Lee CW, Hong MK, Kim PJ, Chung WS, Tahk SJ, Park SW, Park SJ. Effectiveness of sirolimus eluting stent implantation for the treatment of ostial left anterior descending artery stenosis with intravascular ultrasound guidance. J Am Coll Cardiol 2005;46:787-92.
8. Lee SW, Park SW, Hong MK, Kim YH, Lee BK, Song JM, Han KH, Lee CW, Kang DH, SongJK, Kim JJ, Park SJ. Triple versus dual antiplatelet therapy after coronary stenting: impact on stent thrombosis. J Am Coll Cardiol 2005;46:1833-7.
9. Hong MK, Mintz GS, Lee CW, Park DW, Park KM, Lee BK, Kim YH, Song JM, Han KH, Kang DH, Cheong SS, Song JK, Kim JJ, Park SW, Park SJ. Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up. Circulation 2006;113:414-9.
10. Lee CW, Park DW, Lee BK, Kim YH, Hong MK, Kim JJ, Park SW, Park SJ. Predictors of restenosis after placement of drug-eluting stents in one or more coronary arteries. Am J Cardiol 2006;97:506-11.
11. Park KH, Park SW, Hong MK, Kim YH, Lee BK, Park DW, Choi BR, Kim MJ, Park KM, Lee CW, Cheong SS, Kim JJ, Park SJ. Comparison of the effectiveness of sirolimus- and paclitaxel-eluting stents for small coronary artery lesions. Catheter Cardiovasc Interv 2006;67:589-94.
12. Jang JS, Hong MK, Lee CW, Park DW, Lee BK, Kim YH, Han KH, Kim JJ, Park SW, Park SJ. Comparison between sirolimus and Paclitaxel eluting stents for the treatment of chronic total occlusions. J Invasive Cardiol 2006;18:205-8.
13. Park CB, Lee CW, Lee BK, Kim YH, Hong MK, Kim JJ, Park SW, Park SJ. Safety and efficacy with drug eluting stent in ST segment elevation and non ST segment elevation myocardial infarction. Clin Cardiol 2006;29:199-203.
14. Kim YH, Park SW, Hong MK, Park DW, Park KM, Lee BK, Song JM, Han KH, Lee CW, Kang DH, Song JK, Kim JJ, Park SJ. Comparison of simple and complex stenting techniques in the treatment of unprotected left main coronary artery bifurcation stenosis. Am J Cardiol 2006;97:1597-601.
15. Park DW, Park SW, Park KH, Lee BK, Kim YH, Lee CW, Hong MK, Kim JJ, Park SJ. Frequency of and risk factors for stent thrombosis after drug eluting stent implantation during long-term follow-up.Am J Cardiol 2006;98:352-6.
16. Kim YH, Lee BK, Park DW, Park KH, Choi BR, Lee CW, Hong MK, Kim JJ, Park SW, Park SJ. Comparison with conventional therapies of repeated sirolimus eluting stent implantation for the treatment of drug-eluting coronary stent restenosis. Am J Cardiol 2006;98:1451-4.
17. Kim YH, Ahn JM, Park DW, Lee BK, Lee CW, Hong MK, Kim JJ, Park SW, Park SJ. EuroSCORE as a predictor of death and myocardial infarction after unprotected left main coronary stenting. Am J Cardiol 2006;98:1567-70.
18. Hong MK, Mintz GS, Lee CW, Park KM, Lee BK, Kim YH, Kang DH, Cheong SS, Song JK, Kim JJ, Park SW, Park SJ. Plaque ruptures in stable angina pectoris compared with acute coronary syndrome. Int J Cardiol 2007;114:78-82.
19. Lee BK, Hong MK, Lee CW, Choi BR, Kim MJ, Park KH, Kim YH, Han KH, Kim JJ, Park SW, Park SJ. Five year outcomes after stenting of unprotected left main coronary artery stenosis in patients with normal left ventricular function. Int J Cardiol 2007;115:208-13.
20. Lee BK, Lee SW, Park SW, Lee SW, Park DW, Kim YH, Lee CW, Hong MK, Kim JJ, Jang S, Chi HS, Park SJ.Am J Cardiol. Effects of triple antiplatelet therapy (aspirin, clopidogrel, and cilostazol) on platelet aggregation and P selectin expression in patients undergoing coronary artery stent implantation. Am J Cardiol 2007;100:610-4.
21. Cho BR, Kim MK, Suh DH, Hahn JH, Lee BG, Choi YC, Kwon TJ, Kim SY, Kim DJ.Increased tissue transglutaminase expression in human atherosclerotic coronary arteries. Coron Artery Dis 2008;19:459-68.
22. Lee JY, Kim JH, Chae G, Lee BK, Ha KS, Kwon YG, Kim YM. Cyclic AMP prolongs graft survival by suppressing apoptosis and inflammatory gene expression in acute cardiac allograft rejection. Exp Mol Med 2010;42:69-79.
24. Lee SW, Park SW, Kim YH, Yun SC, Park DW, Lee CW, Kang SJ, Park SJ, Lee JH, Choi SW, Seong IW, Lee NH, Cho YH, Shin WY, Lee SJ, Lee SW, Hyon MS, Bang DW, Choi YJ, Kim HS, Lee BK, Lee K, Park HK, Park CB, Lee SG, Kim MK, Park KH, Park WJ; DECLARE-LONG II Study Investigators. A randomized, double blind, multicenter comparison study of triple antiplatelet therapy with dual antiplatelet therapy to reduce restenosis after drug eluting stent implantation in long coronary lesions: results from the DECLARE_LONG II (Drug eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients with Long Coronary Lesions) trial. J Am Coll Cardiol. 2011;57:1264-70.
25. Lee SW, Kim WJ, Kim YH, Park SW, Park DW, Yun SC, Lee JY, Kang SJ, Lee CW, Lee JH, Choi SW, Seong IW, Suh J, Cho YH, Lee NH, Cheong SS, Yoo SY, Lee BK, Lee SG, Hyon MS, Shin WY, Lee SW, Jang JS, Park SJ. Preventive strategies of renal insufficiency in patients with diabetes undergoing intervention or arteriography (the PREVENT Trial). Am J Cardiol. 2011;107:1447-52.
26. Nam CW, Rha SW, Koo BK, Doh JH, Chung WY, Yoon MH, Tahk SJ, Lee BK, Lee JB, Yoo KD, Cho YK, Chung IS, Hur SH, Kim KB, Choi CU, Oh DJ. Usefulness of coronary pressure measurement for functional evaluation of drug-eluting stent restenosis. Am J Cardiol. 2011;107:1783-6.
27. Kim WJ, Lee SW, Park SW, Kim YH, Yun SC, Lee JY, Park DW, Kang SJ, Lee CW, Lee JH, Choi SW, Seong IW, Lee BK, Lee NH, Cho YH, Shin WY, Lee SJ, Lee SW, Hyon MS, Bang DW, Park WJ, Kim HS, Chae JK, Lee K, Park HK, Park CB, Lee SG, Kim MK, Park KH, Choi YJ, Cheong SS, Yang TH, Jang JS, Her SH, Park SJ. Randomized comparison of everolimus-eluting stent versus sirolimus-eluting stent implantation for de novo coronary artery disease in patients with diabetes mellitus (ESSENCE-DIABETES): results from the ESSENCE-DIABETES trial. ESSENCE-DIABETES Study Investigators. Circulation. 2011;124:886-92.
28. Park DW, Kim YH, Song HG, Ahn JM, Kim WJ, Lee JY, Kang SJ, Lee SW, Lee CW, Park SW, Yun SC, Seung KB, Yang TH, Lee SG, Lee JH, Seong IW, Cheong SS, Lee BK, Lee NH, Lee SW, Lee SW, Lee K, Kim HS, Jeon DS, Kim MK, Nah DY, Tahk SJ, Park SJ. Comparison of everolimus - and sirolimus-eluting stents in patients with long coronary artery lesions: a randomized LONG-DES-III (Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-III) Trial. JACC Cardiovasc Interv. 2011;4:1096-103.
29. Song HG, Park DW, Kim YH, Ahn JM, Kim WJ, Lee JY, Kang SJ, Lee SW, Lee CW, Park SW, Han S, Seong IW, Lee NH, Lee BK, Lee K, Lee SW, Nah DY, Park SJ. Randomized trial of optimal treatment strategies for in-stent restenosis after drug-eluting stent implantation. J Am Coll Cardiol. 2012 Mar 20;59(12):1093-100.
30. Park DW, Kim YH, Song HG, Ahn JM, Kim WJ, Lee JY, Kang SJ, Lee SW, Lee CW, Park SW, Yun SC, Her SH, Hur SH, Park JS, Kim MK, Choi YS, Kim HS, Cho JH, Lee SG, Park YW, Jeong MH, Lee BK, Lee NH, Lim DS, Yoon J, Seung KB, Shin WY, Rha SW, Kim KS, Tahk SJ, Park BE, Ahn T, Yang JY, Jeong YS, Rhew JH, Park SJ; IRIS-DES Investigators. Outcomes after unrestricted use of everolimus-eluting and sirolimus-eluting stents in routine clinical practice: a multicenter, prospective cohort study. Circ Cardiovasc Interv. 2012 Jun;5(3):365-71.
31. Ahn JM, Park DW, Kim YH, Song H, Cho YR, Kim WJ, Lee JY, Kang SJ, Lee SW, Lee CW, Park SW, Yun SC, Han S, Lee SY, Lee BK, Cho JH, Yang TH, Lee NH, Yang JY, Park JS, Shin WY, Kim MH, Bae JH, Kim MK, Yoon J, Park SJ. Comparison of resolute zotarolimus-eluting stents and sirolimus-eluting stents in patients with de novo long coronary artery lesions: a randomized LONG-DES IV trial. Circ Cardiovasc Interv. 2012 Oct;5(5):633-40.
32. Koo BK, Lee SP, Lee JH, Park KW, Suh JW, Cho YS, Chung WY, Doh JH, Nam CW, Yu CW, Lee BK, Vassilev D, Gil R, Lim HS, Tahk SJ, Kim HS. Assessment of clinical, electrocardiographic, and physiological relevance of diagonal branch in left anterior descending coronary artery bifurcation lesions. JACC Cardiovasc Interv. 2012 Nov;5(11):1126-32.
33. Lee BK, Kim YH, Park DW, Yun SC, Ahn JM, Song HG, Lee JY, Kim WJ, Kang SJ, Lee SW, Lee CW, Lee JH, Seong IW, Park SW, Park SJ. Acute and long-term angiographic outcomes of side branch stenosis after randomized treatment of zotarolimus-, sirolimus-, and paclitaxel-eluting stent for coronary artery stenosis. J Korean Med Sci. 2012 Dec;27(12):1499-506.
34. Ryu DR, Heo JW, Lee SH, Lee W, Choi JW, Kim HY, Lee BK, Cho BR. Fulminant myocarditis: the role of cardiac magnetic resonance imaging. Int J Cardiol. 2013 Sep 30;168(2):e58-9.
35. Park GM, Lee SW, Park SW, Kim YH, Yun SC, Cho YR, Ahn JM, Lee JY, Kim WJ, Park DW, Kang SJ, Lee CW, Lee BK, Lee NH, Cho YH, Suh J, Shin WY, Lee SJ, Lee SW, Park WJ, Kim HS, Lee SG, Cheong SS, Her SH, Park MW, Kim CJ, Park SJ. Comparison of Zotarolimus-Eluting stent versus Sirolimus-Eluting stent for de novo coronary artery disease in patients with diabetes mellitus from the ESSENCE-DIABETES II trial. Am J Cardiol. 2013 Nov 15;112(10):1565-70.
36. Lee CW, Ahn JM, Park DW, Kang SJ, Lee SW, Kim YH, Park SW, Han S, Lee SG, Seong IW, Rha SW, Jeong MH, Lim DS, Yoon JH, Hur SH, Choi YS, Yang JY, Lee NH, Kim HS, Lee BK, Kim KS, Lee SU, Chae JK, Cheong SS, Suh IW, Park HS, Nah DY, Jeon DS, Seung KB, Lee K, Jang JS, Park SJ. Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a randomized, controlled trial. Circulation. 2014 Jan 21;129(3):304-12.
37. Choi DH, Lee SJ, Kang CD, Park MO, Choi DW, Kim TS, Lee W, Cho BR, Kim YH, Lee BK, Ryu DR, Lee JW. Nonalcoholic fatty liver disease is associated with coronary artery disease in Koreans. World J Gastroenterol. 2013 Oct 14;19(38):6453-7.
38. Lee JY, Park DW, Kim YH, Ahn JM, Kim WJ, Kang SJ, Lee SW, Lee CW, Park SW, Yun SC, Yang TH, Lee BK, Lee NH, Yang JY, Shin WY, Park HS, Kim KS, Hur SH, Lee SY, Park JS, Choi YS, Lee SU, Her SH, Park SJ. Comparison of biolimus A9-eluting (Nobori) and everolimus-eluting (Promus Element) stents in patients with de novo native long coronary artery lesions: a randomized long drug-eluting stent V trial. Circ Cardiovasc Interv. 2014 Jun;7(3):322-9.
39. Park SJ, Lee CW, Ahn JM, Park DW, Kang SJ, Lee SW, Kim YH, Park SW, Han S, Lee SG, Seong IW, Rha SW, Jeong MH, Lim DS, Yoon JH, Hur SH, Choi YS, Yang JY, Lee NH, Kim HS, Lee BK, Kim KS, Lee SU, Chae JK, Cheong SS, Suh IW, Park HS, Nah DY, Jeon DS, Seung KB, Lee K, Jang JS. Response to letter regarding article, """"""""""""""""""""""""""""""""optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a randomized, controlled trial"""""""""""""""""""""""""""""""". Circulation. 2014 Oct 28;130(18):e161-2.
40. Lim HS, Tonino PA, De Bruyne B, Yong AS, Lee BK, Pijls NH, Fearon WF. The impact of age on fractional flow reserve-guided percutaneous coronary intervention: a FAME (Fractional Flow Reserve versus Angiography for Multivessel Evaluation) trial substudy. Int J Cardiol. 2014 Nov 15;177(1):66-70.
41. Ryu DR, Choi JW, Lee BK, Cho BR. Effects of Critical Pathway on the Management of Patients With ST-elevation Acute Myocardial Infarction in an Emergency Department. Crit Pathw Cardiol. 2015 Mar;14(1):31-5.
42. Lee BK, Lim HS, Fearon WF, Yong A, Yamada R, Tanaka S, Lee DP, Yeung AC, Tremmel JA. Invasive Evaluation of Patients with Angina in the Absence of Obstructive Coronary Artery Disease. Circulation. 2015 Mar 24;131(12):1054-60.
43. Park SJ, Ahn JM, Kim YH, Park DW, Yun SC, Lee JY, Kang SJ, Lee SW, Lee CW, Park SW, Choo SJ, Chung CH, Lee JW, Cohen DJ, Yeung AC, Hur SH, Seung KB, Ahn TH, Kwon HM, Lim DS, Rha SW, Jeong MH, Lee BK, Tresukosol D, Fu GS, Ong TK; BEST Trial Investigators. Trial of everolimus-eluting stents or bypass surgery for coronary disease. N Engl J Med. 2015 Mar 26;372(13):1204-12.
44. Kim YH, Lee JH, Roh JH, Ahn JM, Yoon SH, Park DW, Lee JY, Yun SC, Kang SJ, Lee SW, Lee CW, Seung KB, Shin WY, Lee NH, Lee BK, Lee SG, Nam CW, Yoon J, Yang JY, Hyon MS, Lee K, Jang JS, Kim HS, Park SW, Park SJ. Randomized Comparisons Between Different Stenting Approaches for Bifurcation Coronary Lesions With or Without Side Branch Stenosis. JACC Cardiovasc Interv. 2015 Apr 20;8(4):550-60.
45. Tremmel JA, Fearon WF, Lee BK, Lim HS, Yong AS, Yamada R, Tanaka S, Lee DP, Yeung AC. Response to Letters Regarding Article, """"""""""""""""""""""""""""""""Invasive Evaluation of Patients With Angina in the Absence of Obstructive Coronary Artery Disease"""""""""""""""""""""""""""""""". Circulation. 2015 Nov 17;132(20):e244.
46. Park SH, Jeon KH, Lee JM, Nam CW, Doh JH, Lee BK, Rha SW, Yoo KD, Jung KT, Cho YS, Lee HY, Youn TJ, Chung WY, Koo BK. Long-Term Clinical Outcomes of Fractional Flow Reserve-Guided Versus Routine Drug-Eluting Stent Implantation in Patients With Intermediate Coronary Stenosis: Five-Year Clinical Outcomes of DEFER-DES Trial. Circ Cardiovasc Interv. 2015 Dec;8(12):e002442
47. Lee BK, Koo BK, Nam CW, Doh JH, Chung WY, Cho BR, Fearon WF. Does Pre-Treatment with High Dose Atorvastatin Prevent Microvascular Dysfunction after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome? Korean Circ J. 2016 Jul;46(4):472-80.
48. Lee BK, Kim SW, Choi D, Cho EH. Comparison of Age of Onset and Frequency of Diabetic Complications in the Very Elderly Patients with Type 2 Diabetes. Endocrinol Metab. 2016 Sep;31(3):416-423.
49. Hong SJ, Jeong HS, Han SH, Chang KY, Hong BK, Lee BK, Chae SC, Kim WS, Park CG, Heo JH, Lee SU, Kim YD, Kim KS, Choi JH, Kang HJ, Kim JJ, Kang SM, Choi YJ, Shin JH, Chun KJ, Shin DG, Park SH, Kwan J, Choi YJ, Jeong MH, Chae JK, Kim DW, Cho JR, Han KR, Won KH, Park SH, Lee SK, Kim SH, Jung J, Kim CH.Comparison of Fixed-dose Combinations of Amlodipine/Losartan Potassium/Chlorthalidone and Amlodipine/Losartan Potassium in Patients With Stage 2 Hypertension Inadequately Controlled With Amlodipine/Losartan Potassium: A Randomized, Double-blind, Multicenter, Phase III Study. Clin Ther. 2017 Oct;39(10):2049-2060
50. Kang J, Koo BK, Hu X, Lee JM, Hahn JY, Yang HM, Shin ES, Nam CW, Doh JH, Lee BK, Ahn C, Wang J, Tahk SJ. Comparison of Fractional FLow Reserve And Intravascular ultrasound-guided Intervention Strategy for Clinical OUtcomes in Patients with InteRmediate Stenosis (FLAVOUR): Rationale and design of a randomized clinical trial. Am Heart J. 2018 May;199:7-12
51. Seo JH, Chun KJ, Lee BK, Cho BR, Ryu DR. Statins Have No Role in Preventing the Progression of Aortic Valve Sclerosis. J Cardiovasc Imaging. 2018 Dec;26(4):229-237
52. Kang DY, Lee CH, Lee PH, Ahn JM, Lee SW, Kim YH, Park SW, Nam CW, Choi YS, Rha SW, Cho JH, Kim W, Her SH, Jeong MH, Yang JY, Lee BK, Park HS, Park DW, Park SJ. Comparison of Resolute zotarolimus-eluting and Xience everolimus-eluting stents in patients with de novo long coronary artery lesions: a randomized LONG-DES VI trial. Coron Artery Dis. 2019 Jan;30(1):59-66
53. Lee SW, Lee PH, Ahn JM, Park DW, Yun SC, Han S, Kang H, Kang SJ, Kim YH, Lee CW, Park SW, Hur SH, Rha SW, Her SH, Choi SW, Lee BK, Lee NH, Lee JY, Cheong SS, Kim MH, Ahn YK, Lim SW, Lee SG, Hiremath S, Santoso T, Udayachalerm W, Cheng JJ, Cohen DJ, Muramatsu T, Tsuchikane E, Asakura Y, Park SJ. Randomized Trial Evaluating Percutaneous Coronary Intervention for the Treatment of Chronic Total Occlusion. Circulation. 2019 Apr 2;139(14):1674-1683
54. Kim JS, Lee BK, Ryu DR, Chun KJ, Choi HH, Roh Y, Kwon SM, Cho BR. A MULTICENTRE SURVEY OF LOCAL DIAGNOSTIC REFERENCE LEVELS AND ACHIEVABLE DOSE FOR CORONARY ANGIOGRAPHY AND PERCUTANEOUS TRANSLUMINAL CORONARY INTERVENTION PROCEDURES IN KOREA. Radiat Prot Dosimetry. 2019;187(3):378-382.
55. Youn YJ, Yoo SY, Lee JW, Ahn SG, Lee SH, Yoon J, Park JH, Choi WG, Cho S, Lim SW, Jang YS, Kwon KH, Lee NH, Doh JH, Kang WC, Jeon DW, Lee BK, Heo JH, Hong BK, Choi HH. Safety and Efficacy of a New Ultrathin Sirolimus-Eluting Stent with Abluminal Biodegradable Polymer in Real-World Practice. Korean Circ J. 2020;50(4):317-327
56. Kim JS, Lee BK, Ryu DR, Chun K, Kwon HS, Nam SR, Kim DI, Lee SY, Jeong JO, Bae JW, Park JS, Ahn Y, Chae JK, Yoon MH, Lee SH, Yoon J, Gwon HC, Choi D, Kwon SM, Roh YH, Cho BR. Occupational radiation exposure in femoral artery approach is higher than radial artery approach during coronary angiography or percutaneous coronary intervention. Sci Rep. 2020;10(1):7104
57. Yoon YH, Ahn JM, Kang DY, Park H, Cho SC, Lee PH, Hur SH, Kim WJ, Park CS, Lee BK, Suh JW, Yoon JH, Choi JW, Kim KS, Choi SW, Lee SN, Park SJ, Park DW. Pragmatic trial comparing routine versus no routine functional testing in high-risk patients who underwent percutaneous coronary intervention: Rationale and design of POST-PCI trial. Am Heart J. 2020;224:156-165
58. Lee KY, Lee BK, Kim WJ, Kang SH, Park TK, Kim SY, Suh JW, Yoon CH, Yang DH, Ryu SK, Kim SH, Lee SY, Chae IH; Korean Society of Interventional Cardiology COVID-19 Task Force Team. Consensus statement on coronary intervention during the coronavirus disease 19 pandemic: from the Korean Society of Interventional Cardiology. Korean J Intern Med. 2020;35(4):749-757.
59. Kim HS, Kang J, Hwang D, Han JK, Yang HM, Kang HJ, Koo BK, Rhew JY, Chun KJ, Lim YH, Bong JM, Bae JW, Lee BK, Park KW; HOST-REDUCE-POLYTECH-ACS investigators. Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trial. Lancet 2020;396(10257):1079-1089
60. Roh Y, Nam S, Lee BK, Ryu DR, Chun K, Lee KS, Cho N, Yoon Y, Park H, Cho BR, Kim JS. Radiation exposure of interventional cardiologists during coronary angiography: evaluation by phantom measurement and computer simulation. Phys Eng Sci Med. 2020;43(4):1279-1287
61. Lee KY, Lee BK, Kim WJ, Kang SH, Park TK, Kim SY, Suh JW, Yoon CH, Yang DH, Ryu SK, Kim SH, Lee SY, Chae IH; Korean Society of Interventional Cardiology COVID-19 Task Force Team. Consensus Statement on Coronary Intervention during the Coronavirus Disease 2019 (COVID-19) Pandemic: from the Korean Society of Interventional Cardiology (KSIC). Korean Circ J. 2020;50(11):974-983
62. Kim HS, Kang J, Hwang D, Han JK, Yang HM, Kang HJ, Koo BK, Rhew JY, Chun KJ, Lim YH, Bong JM, Bae JW, Lee BK, Park KW; HOST-REDUCE-POLYTECH-ACS investigators. Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trial. Lancet. 2020 Oct 10;396(10257):1079-1089
63. Roh Y, Nam S, Lee BK, Ryu DR, Chun K, Lee KS, Cho N, Yoon Y, Park H, Cho BR, Kim JS. Radiation exposure of interventional cardiologists during coronary angiography: evaluation by phantom measurement and computer simulation. Phys Eng Sci Med. 2020 Dec;43(4):1279-1287
64. Sgueglia GA, Lee BK, Cho BR, Babunashvili A, Lee JB, Lee JW, Schenke K, Lee SY, Harb S. Distal Radial Access: Consensus Report of the First Korea-Europe Transradial Intervention Meeting. JACC Cardiovasc Interv. 2021 Apr 26;14(8):892-906
65. Ki YJ, Lee BK, Park KW, Bae JW, Hwang D, Kang J, Han JK, Yang HM, Kang HJ, Koo BK, Kim DB, Chae IH, Moon KW, Park HW, Won KB, Jeon DW, Han KR, Choi SW, Ryu JK, Jeong MH, Cha KS, Kim HS; HOST-RP-ACS investigators. Prasugrel-based De-Escalation of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With STEMI. Korean Circ J. 2022 Apr;52(4):304-319
66. Seo JH, Kim KH, Chun KJ, Lee BK, Cho BR, Ryu DR. Impact of Total Ischemic Time on the Recovery of Regional Wall Motion Abnormality after STEMI in the Modern Reperfusion Era. J Interv Cardiol. 2022 Jan 22;2022:2447707
67. Kim SH, Lim KR, Seo JH, Ryu DR, Lee BK, Cho BR, Chun KJ. Higher heart rate variability as a predictor of atrial fibrillation in patients with hypertension. Sci Rep. 2022 Mar 8;12(1):3702
68. Park DW, Kang DY, Ahn JM, Yun SC, Yoon YH, Hur SH, Lee CH, Kim WJ, Kang SH, Park CS, Lee BK, Suh JW, Yoon JH, Choi JW, Kim KS, Choi SW, Lee SN, Park SJ; POST-PCI Investigators. Routine Functional Testing or Standard Care in High-Risk Patients after PCI. N Engl J Med. 2022 Sep 8;387(10):905-915
69. Koo BK, Hu X, Kang J, Zhang J, Jiang J, Hahn JY, Nam CW, Doh JH, Lee BK, Kim W, Huang J, Jiang F, Zhou H, Chen P, Tang L, Jiang W, Chen X, He W, Ahn SG, Yoon MH, Kim U, Lee JM, Hwang D, Ki YJ, Shin ES, Kim HS, Tahk SJ, Wang J; FLAVOUR Investigators. Fractional Flow Reserve or Intravascular Ultrasonography to Guide PCI. N Engl J Med. 2022 Sep 1;387(9):779-789
70. Ahn JM, Kang DY, Yun SC, Hur SH, Park HJ, Tresukosol D, Kang WC, Kwon HM, Rha SW, Lim DS, Jeong MH, Lee BK, Huang H, Lim YH, Bae JH, Kim BO, Ong TK, Ahn SG, Chung CH, Park DW, Park SJ. Everolimus-Eluting Stents or Bypass Surgery for Multivessel Coronary Artery Disease: Extended Follow-up Outcomes of Multicenter Randomized Controlled BEST Trial. Circulation. 2022 Nov 22;146(21):1581-1590
71. Lee JM, Kim HK, Park KH, Choo EH, Kim CJ, Lee SH, Kim MC, Hong YJ, Ahn SG, Doh JH, Lee SY, Park SD, Lee HJ, Kang MG, Koh JS, Cho YK, Nam CW, Koo BK, Lee BK, Yun KH, Hong D, Joh HS, Choi KH, Park TK, Yang JH, Song YB, Choi SH, Gwon HC, Hahn JY; FRAME-AMI Investigators. Fractional flow reserve versus angiography-guided strategy in acute myocardial infarction with multivessel disease: a randomized trial. Eur Heart J. 2023 Feb 7;44(6):473-484
72. Lee KS, Park KH, Park KW, Rha SW, Hwang D, Kang J, Han JK, Yang HM, Kang HJ, Koo BK, Lee NH, Rhew JY, Chun KJ, Lim YH, Bong JM, Bae JW, Lee BK, Kim SY, Shin WY, Lim HS, Park K, Kim HS. Prasugrel dose de-escalation in diabetic patients with acute coronary syndrome receiving percutaneous coronary intervention: Results from HOST-REDUCE-POLYTECH-ACS trial. Eur Heart J Cardiovasc Pharmacother. 2023 Jan 28. Online ahead of print.
73. Jeong Hun Seo, Kang Hee Kim, Kwang Jin Chun, Bong-Ki Lee, Byung-Ryul Cho, Dong Ryeol Ryu. How can progression be predicted in patients with mild to moderate aortic valve stenosis? Eur Heart J Cardiovasc Imaging. 2023 Aug 23;24(9):1146-1153
74. Jung-Min Ahn, Do-Yoon Kang, Pil Hyung Lee, Young-Keun Ahn, Won-Jang Kim, Chang-Wook Nam, Jin-Ok Jeong, In-Ho Chae 6, Hiroki Shiomi, Paul Hsien Li Kao, Joo-Yong Hahn, Sung-Ho Her, Bong-Ki Lee, Tae Hoon Ahn, Kiyuk Chang, Jei Keon Chae, David Smyth, Gregg W Stone, Duk-Woo Park, Seung-Jung Park; PREVENT Investigators. Preventive PCI or medical therapy alone for vulnerable atherosclerotic coronary plaque: Rationale and design of the randomized, controlled PREVENT trial. Am Heart J. 2023 Oct:264:83-96
75. Young Jin Youn, Jun-Won Lee, Sung Gyun Ahn, Seung-Hwan Lee, Junghan Yoon, Jae Hyoung Park, Sang-Yong Yoo, Woong Chol Kang, Nam Ho Lee, Ki Hwan Kwon, Joon Hyung Doh, Sang-Wook Lim, Yang Soo Jang, Dong Woon Jeon, Jung Ho Heo, Woong Gil Choi, Sungsoo Cho, Bong-Ki Lee, Hyonju Jeong, Bum-Kee Hong, Hyun-Hee Choi. Clinical safety and effectiveness of the Genoss drug-eluting stent in real-world clinical practice. Korean J Intern Med. 2023 Sep;38(5):683-691
76. Jeong Hun Seo, Kang Hee Kim, Kwang Jin Chun, Bong-Ki Lee, Byung-Ryul Cho, Dong Ryeol Ryu. Impact of low-density lipoprotein cholesterol on progression of aortic valve sclerosis and stenosis. Front Cardiovasc Med. 2023 Jul 17:10:1171703
77. Jinlong Zhang, Jun Jiang, Xinyang Hu, Yong Sun, Changling Li, Lingjun Zhu, Feng Gao, Liang Dong, Yabin Liu, Jian Shen, Cheng Ni, Kan Wang, Zexin Chen, Haibo Chen, Shiqiang Li, Seokhun Yang, Jeehoon Kang, Doyeon Hwang, Joo-Yong Hahn, Chang-Wook Nam, Joon-Hyung Doh, Bong-Ki Lee, Weon Kim, Jinyu Huang, Fan Jiang, Hao Zhou, Peng Chen, Lijiang Tang, Wenbing Jiang, Xiaomin Chen, Wenming He, Sung Gyun Ahn, Myeong-Ho Yoon, Ung Kim, Joo Myung Lee, You-Jeong Ki, Eun-Seok Shin, Chee Hae Kim, Seung-Jea Tahk, Bon-Kwon Koo, Jian''''''''''''''''''''''''''''''''an Wang. Sex Differences in Fractional Flow Reserve- or Intravascular Ultrasound-Guided Percutaneous Coronary Intervention. JACC Cardiovasc Interv. 2023 Oct 9;16(19):2426-2435
78. Chi Young Bang, Chanho Jeong, Seung Ho Lee, Kunyong Sung, Bong-Ki Lee, Sang-Yeul Lee. Salvage percutaneous transluminal angioplasty of the superficial femoral artery in the diabetic foot with deteriorating limb ischemia. Wounds. 2023 Aug;35(8):E261-E264
79. Kang Hee Kim, Bong-Ki Lee, Jeong Hun Seo, Kwang Jin Chun, Byung-Ryul Cho. Successful coronary angiography via distal radial access in an 82-year-old male patient with polydactyly. Korean J Intern Med. 2024 Jan;39(1):196-197
80. Hoyun Kim, Do-Yoon Kang, Jung-Min Ahn, Jinho Lee, Yeonwoo Choi, Seung Ho Hur, Hun-Jun Park, Damras Tresukosol, Woong Chol Kang, Hyuck Moon Kwon, Seung-Woon Rha, Do-Sun Lim, Myung-Ho Jeong, Bong-Ki Lee, He Huang, Young-Hyo Lim, Jang Ho Bae, Byung Ok Kim, Tiong Kiam Ong, Sung Gyun Ahn, Cheol-Hyun Chung, Duk-Woo Park, Seung-Jung Park; BEST Extended Follow-Up Study Investigators. Everolimus-Eluting Stents or Bypass Surgery for Multivessel Disease in Diabetics: The BEST Extended Follow-Up Study. JACC Cardiovasc Interv. 2023 Oct 9;16(19):2412-2422
81. Jaeho Seung, Eun Ho Choo, Chan Joon Kim, Hyun Kuk Kim, Keun Ho Park, Seung Hun Lee, Min Chul Kim, Young Joon Hong, Sung Gyun Ahn, Joon-Hyung Doh, Sang Yeub Lee, Sang Don Park, Hyun-Jong Lee, Min Gyu Kang, Jin-Sin Koh, Yun-Kyeong Cho, Chang-Wook Nam, Bon-Kwon Koo, Bong-Ki Lee, Kyeong Ho Yun, David Hong, Hyun Sung Joh, Ki Hong Choi, Taek Kyu Park, Joo Myung Lee, Jeong Hoon Yang, Young Bin Song, Seung-Hyuk Choi, Hyeon-Cheol Gwon, Joo-Yong Hahn; FRAME-AMI Investigators. Angiographic Severity of the Nonculprit Lesion and the Efficacy of Fractional Flow Reserve-Guided Complete Revascularization in Patients With AMI: FRAME-AMI Substudy. Circ Cardiovasc Interv. 2024 Jan;17(1):e013611
82. Hoyun Kim, Do-Yoon Kang, Jinho Lee, Yeonwoo Choi, Jung-Min Ahn, Seonok Kim, Yong-Hoon Yoon, Seung-Ho Hur, Cheol Hyun Lee, Won-Jang Kim, Se Hun Kang, Chul Soo Park, Bong-Ki Lee, Jung-Won Suh, Jae Woong Choi, Kee-Sik Kim, Su Nam Lee, Seung-Jung Park, Duk-Woo Park. Routine stress testing in diabetic patients after percutaneous coronary intervention: the POST-PCI trial. Eur Heart J. 2024 Mar 1;45(9):653-665
83. Joo Myung Lee, Hangyul Kim, David Hong, Doyeon Hwang, Jinlong Zhang, Xinyang Hu, Jun Jiang, Chang-Wook Nam, Joon-Hyung Doh, Bong-Ki Lee, Weon Kim, Jinyu Huang, Fan Jiang, Hao Zhou, Peng Chen, Lijiang Tang, Wenbing Jiang, Xiaomin Chen, Wenming He, Jeehoon Kang, Sung-Gyun Ahn, Myeong-Ho Yoon, Ung Kim, You-Jeong Ki, Eun-Seok Shin, Ki Hong Choi, Taek Kyu Park, Jeong Hoon Yang, Young Bin Song, Seung-Hyuk Choi, Hyeon-Cheol Gwon, Bon-Kwon Koo, Hyo-Soo Kim, Seung-Jea Tahk, Jian''''''''''''''''''''''''''''''''an Wang, Joo-Yong Hahn; FLAVOUR Investigators. Clinical Outcomes of Deferred Lesions by IVUS Versus FFR-Guided Treatment Decision. Circ Cardiovasc Interv. 2023 Dec;16(12):e013308
84. Seokhun Yang, Jeehoon Kang, Doyeon Hwang, Jinlong Zhang, Jun Jiang, Xinyang Hu, Joo-Yong Hahn, Chang-Wook Nam, Joon-Hyung Doh, Bong-Ki Lee, Weon Kim, Jinyu Huang, Fan Jiang, Hao Zhou, Peng Chen, Lijiang Tang, Wenbing Jiang, Xiaomin Chen, Wenming He, Sung Gyun Ahn, Myeong-Ho Yoon, Ung Kim, Joo Myung Lee, You-Jeong Ki, Eun-Seok Shin, Hyo-Soo Kim, Seung-Jea Tahk, Jian''''''''''''''''''''''''''''''''an Wang, Bon-Kwon Koo. Physiology- or Imaging-Guided Strategies for Intermediate Coronary Stenosis. 2024 Jan 2;7(1):e2350036. doi: 10.1001
85. You-Jeong Ki, Jeehoon Kang, Jinlong Zhang, Xinyang Hu, Jun Jiang, Joo-Yong Hahn, Chang-Wook Nam, Joon-Hyung Doh, Bong-Ki Lee, Weon Kim, Jinyu Huang, Fan Jiang, Hao Zhou, Peng Chen, Lijiang Tang, Wenbing Jiang, Xiaomin Chen, Wenming He, Sung-Gyun Ahn, Myeong-Ho Yoon, Ung Kim, Doyeon Hwang, Eun-Seok Shin, Hyo-Soo Kim, Seung-Jea Tahk, Jian''''''''''''''''''''''''''''''''an Wang, Bon-Kwon Koo. Prognostic Implications of Quantitative Flow Ratio and Plaque Characteristics in Intravascular Ultrasound-Guided Treatment Strategy. JACC Cardiovasc Interv. 2024 Feb 26;17(4):461-470
86. Jun-Won Lee, Yongcheol Kim, Bong-Ki Lee, Sang-Yong Yoo, Sang Yeub Lee, Chan Joon Kim, Han-Young Jin, Jin Sup Park, Jung Ho Heo, Do Hoi Kim, Jin Bae Lee, Dong-Kie Kim, Jun Ho Bae, Sung-Yun Lee, Seung-Hwan Lee. Distal Radial Access for Coronary Procedures in a Large Prospective Multicenter Registry: The KODRA Trial. JACC Cardiovasc Interv. 2024 Feb 12;17(3):329-340
87. Joong Min Lee, Hoyun Kim, Young-Sun Park, Ha Hye Jo, So-Min Lim, Jinho Lee, Yeonwoo Choi, Do-Yoon Kang, Jung-Min Ahn, Seonok Kim, Yong-Hoon Yoon, Seung-Ho Hur, Cheol Hyun Lee, Won-Jang Kim, Se Hun Kang, Chul Soo Park, Bong-Ki Lee, Jung-Won Suh, Jae Woong Choi, Kee-Sik Kim, Su Nam Lee, Seung-Jung Park, Duk-Woo Park; POST-PCI Investigators. Surveillance Stress Testing After Percutaneous Intervention for Patients With Multivessel or Left Main Coronary Disease. J Am Coll Cardiol. 2024 Mar 5;83(9):890-900
88. Bong-Ki Lee. Prasugrel Only May Be Enough After Percutaneous Coronary Intervention for Chronic Coronary Syndrome Patients. JACC Asia. 2024 Jan 30;4(3):183-184 88. Seung-Jung Park, Jung-Min Ahn, Do-Yoon Kang, Sung-Cheol Yun, Young-Keun Ahn, Won-Jang Kim, Chang-Wook Nam, Jin-Ok Jeong, In-Ho Chae, Hiroki Shiomi, Hsien-Li Kao, Joo-Yong Hahn, Sung-Ho Her, Bong-Ki Lee, Tae Hoon Ahn, Ki-Yuk Chang, Jei Keon Chae, David Smyth, Gary S Mintz, Gregg W Stone, Duk-Woo Park; PREVENT Investigators. Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial. Lancet. 2024 Apr 4:S0140-6736(24)00413-6